SARAVANAN, K. M. and SUNDARAM, K. MEENAKSHI (2021) EFFECT OF BROMOCRIPTINE IN DIABETES MELLITUS: A REVIEW. UTTAR PRADESH JOURNAL OF ZOOLOGY, 42 (24). pp. 1166-1170.
Full text not available from this repository.Abstract
Bromocriptine, an antinociceptive D2 receptor agonist, is thought to reorganize an excessively heightened hypothalamic drive for higher fatty acids, plasma glucose, and tri-glycerides in insulin resistant individuals by acting on circadian neuronal activity in the hypothalamus. In May 2009, the bromocriptine mesylate is officially authorized for the cure of people with diabetes. Due to its novel mechanism of action, lower rates of cardiovascular events and good side effect profile it makes an appealing choice for diabetes cure.
| Item Type: | Article |
|---|---|
| Subjects: | Article Paper Librarian > Biological Science |
| Depositing User: | Unnamed user with email support@article.paperlibrarian.com |
| Date Deposited: | 13 Jan 2024 04:35 |
| Last Modified: | 13 Jan 2024 04:35 |
| URI: | http://editor.journal7sub.com/id/eprint/2094 |
Actions (login required)
- View Item